- Preferred Initial HBV Therapies
- Management of Persistent Viremia and Viral Breakthrough
- Considerations for Special Populations
- Question and Answer Session
Date / Time
Robert S. Brown, Jr., MD, MPH
Gladys and Roland Harriman Professor of Medicine
Vice Chair, Transitions of Care
Clinical Chief, Division of Gastroenterology and Hepatology
Weill Cornell Medicine
New York, New York
Norah Terrault, MD, MPH
Professor of Medicine and Surgery
Director, Viral Hepatitis Center
Division of Gastroenterology
University of California, San Francisco
San Francisco, California
A series of live Webinars in which expert faculty review key data and provide perspectives on the impact of new developments in the care of patients with viral hepatitis.
The goal of this activity is to improve participants’ confidence and competence in incorporating best practices and emerging data into their patient care strategies for patients with viral hepatitis.
This program is intended for physicians, registered nurses, pharmacists, and other healthcare professionals involved in the management of patients with viral hepatitis.
Upon completion of this activity, participants should be able to:
- Implement updated strategies for management of HBV infection based on available treatment options and guidelines
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Clinical Care Options, LLC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Postgraduate Institute for Medicine designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.7 contact hours
A statement of credit will be issued only upon receipt of a completed activity evaluation form.
Pharmacist Continuing Education
Postgraduate Institute for Medicine designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008162-9999-18-058-L02-P.
Type of Activity
Pharmacists have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to CPE Monitor as required.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.